Investors push biotech Imugene to 13-year price high
SYDNEY: Shares in $620 million biotech Imugene today hit their highest since January 2008 after… read more
Ramsay ready for mass vaccine rollout says C.E.O.
SYDNEY: Ramsay Health Care is preparing to provide its medical expertise for the launch of… read more
Biotech news rush delivers boost to entire market
MELBOURNE: A rush of biotech updates from small cap stocks has pushed research-focused firms higher… read more
Jim Breyer set to back Australian health start-up
SYDNEY: Venture capital heavyweight Jim Breyer has made billions placing the right bets on start-ups… read more
